Long-term outcome of highly sensitized African American patients transplanted with deceased donor kidneys

Transplant International

Volumn 24, Issue 3, 2011, Pages 259-265

  Ren, Qing ^a   Paramesh, Anil ^a   Yau, C Lillian ^a   Killackey, Mary ^a   Slakey, Douglas ^a   Florman, Sandy ^a   Buell, Joseph ^a   Alper, Brent ^a   Simon, Eric ^a   Hamm, L Lee ^a   Zhang, Rubin ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

African American; graft survival; kidney transplantation; PRA; rejection; sensitization

Indexed keywords

BASILIXIMAB; CLOTRIMAZOLE; COTRIMOXAZOLE; GANCICLOVIR; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY; VALGANCICLOVIR;

ACUTE GRAFT REJECTION; ADULT; AFRICAN AMERICAN; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CADAVER DONOR; CYTOMEGALOVIRUS INFECTION; DEMOGRAPHY; FEMALE; GRAFT SURVIVAL; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KAPLAN MEIER METHOD; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AFRICAN AMERICANS; FEMALE; GRAFT SURVIVAL; HLA ANTIGENS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LOUISIANA; MALE; MIDDLE AGED; TISSUE DONORS; TREATMENT OUTCOME;

EID: 79551563655     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2010.01188.x     Document Type: Article

References (26)

1. 2008 OPTN/SRTR Annual Report: Transplant Data 1998-2007. Available at: http://www.ustransplant.org/annual-reports/current/ (accessed 3/15/2010).
2. Cecka JM,. Calculated PRA (CPRA): the new measure of sensitization for transplant candidates. Am J Transplant 2010; 10: 26.
3. Montgomery RA,. Renal transplantation across HLA and ABO antibody barriers: integrating paired donation into desensitization protocols. Am J Transplant 2010; 10: 449.
4. Stegall MD, Gloor J, Winters JL, et al. A comparison of Plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody. Am J Transplant 2006; 6: 346.
5. Haririan A, Nogueira J, Kukuruga D, et al. Positive crossmatch living donor kidney transplantation: longer-term outcomes. Am J Transplant 2009; 9: 536.
6. Jordan SC, Tyan D, Stablein D, et al. Evaluation of intravenous immune globulin for desensitization as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end stage renal disease: report of NIH IG02 trial. J Am Soc Nephrol 2004; 15: 3256.
7. Vo AA, Lukovsky M, Toyoda M, et al. Rituximab and intravenous immune globulin for desensitization during renal transplantation. N Engl J Med 2008; 359: 242.
8. Doxiadis IIN, Smits JMA, Persijn GG, et al. It takes six to boogie: allocating cadaver kidneys in Eurotransplant. Transplantation 2004; 77: 615.
9. Claas FHJ, Witvliet MD, Duquesnoy RJ, et al. The acceptable mismatch program as a fast tool for highly sensitized patients awaiting a cadaveric kidney transplantation: short waiting time and excellent graft outcome. Transplantation 2004; 78: 190.
10. Van den Berg-Loonen EM, Billen EVA, Voorter CEM, et al. Clinical relevance of pretransplant donor directed antibodies detected by single antigen beads in highly sensitized renal transplant patients. Transplantation 2008; 85: 1086.
11. Bray RA, Nolen JD, Larsen C, et al. Transplanting the highly sensitized patients: The Emory algorithm. Am J Transplant 2006; 6: 2307.
12. Bingaman AW, Murphey CL, Palma-Vargas J, Wright F,. A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation. Transplantation 2008; 86: 1864.
13. Isaacs RB, Nock SL, Spencer CE, et al. Racial disparities in renal transplant outcomes. Am J Kidney Dis 1999; 34: 706.
14. Fan PY, Ashby VB, Fuller DS, et al. Access and outcomes among minority transplant patients, 1999-2008, with a focus on determinants of kidney graft survival. Am J Transplant 2010; 10: 1090.
15. Higgins RS, Fishman JA,. Disparities in solid organ transplantation for ethnic minorities: facts and solutions. Am J Transplant 2006; 6: 2556.
16. Hidalgo LG, Campbell PM, Sis B, et al. De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure. Am J Transplant 2009; 9: 2532.
17. Kraus ES, Parekh RS, Oberai P, et al. Subclinical rejection in stable positive crossmatch kidney transplant patients: incidence and correlations. Am J Transplant 2009; 9: 1826.
18. Morris GP, Phelan DL, Jendrisak MD, et al. Virtual crossmatch by identification of donor-specific anti-human leukocyte antigen antibodies by solid-phase immunoassay: a 30-month analysis in living donor kidney transplantation. Hum Immunol 2009; 71: 268.
19. Tambur AR, Leventhal J, Kaufman DB, et al. Tailoring antibody testing and how to use it in the calculated panel reactive antibody era: the northwestern university experience. Transplantation 2008; 86: 1052.
20. Zachary AA, Montgomery RA, Leffell MS,. Defining unacceptable HLA antigens. Curr Opin Organ Transplant 2008; 13: 405.
21. Brennan DC, Daller JA, Lake KD, et al. Rabbit antithymocyte globulin versus basiliximab in renal transplantation. N Engl J Med 2006; 355: 1967.
22. Lebranchu Y, Bridoux F, Buchler M, et al. Immunoprophylaxis with basiliximab compared with antithymocyte globulin in renal transplant patients receiving MMF-containing triple therapy. Am J Transplant 2002; 2: 48.
23. Haririan A, Morawski K, Sillix DH, et al. Induction therapy with basiliximab versus thymoglobulin in African American kidney transplant recipients. Transplantation 2005; 79: 716.
24. Jindal RM, Das NP, Neff RT, et al. Outcomes in African-Americans vs. Caucasians using thymoglobulin or interleukin-2 inhibitor induction: analysis of USRD database. Am J Nephrol 2009; 29: 501.
25. Zhang R, Florman S, Devidoss S, et al. The comparison of long-term survivals of simultaneous pancreas-kidney transplant between African American and Caucasian recipients with basiliximab induction therapy. Am J Transplant 2007; 7: 1815.
26. Paramesh AS, Zhang R, Yau CL, et al. A comparison of long-term outcomes of single pediatric kidney transplant between African-American and Non African-American adults. Clin Nephrol 2009; 72: 55.